BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31144430)

  • 1. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide.
    Øhrstrøm CC; Worm D; Højager A; Andersen D; Holst JJ; Kielgast UL; Hansen DL
    Diabetes Obes Metab; 2019 Sep; 21(9):2142-2151. PubMed ID: 31144430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
    Øhrstrøm CC; Worm D; Kielgast UL; Holst JJ; Hansen DL
    Obes Surg; 2020 Mar; 30(3):1038-1045. PubMed ID: 31907828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
    Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
    Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin secretion after Roux-en-Y gastric bypass, sleeve gastrectomy, and truncal vagotomy with pyloroplasty.
    Svane MS; Øhrstrøm CC; Plamboeck A; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Martinussen C; Vilsbøll T; Hartmann B; Deacon CF; Kristiansen VB; Knop FK; Svendsen LB; Madsbad S; Holst JJ; Veedfald S
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14210. PubMed ID: 34378827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass.
    Øhrstrøm CC; Hansen DL; Kielgast UL; Bergmann ML; Veedfald S; Holst JJ; Worm D
    Surg Obes Relat Dis; 2021 Jan; 17(1):55-63. PubMed ID: 33039341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol.
    Lobato CB; Winding CT; Bojsen-Møller KN; Martinussen C; Veedfald S; Holst JJ; Madsbad S; Jørgensen NB; Dirksen C
    Diabet Med; 2024 Jun; 41(6):e15320. PubMed ID: 38551152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals.
    Øhrstrøm CC; Hansen DL; Kielgast UL; Hartmann B; Holst JJ; Worm D
    Obes Surg; 2020 Apr; 30(4):1605-1610. PubMed ID: 31709494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.
    Svane MS; Toft-Nielsen MB; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S; Bojsen-Møller KN
    Diabet Med; 2017 Dec; 34(12):1783-1787. PubMed ID: 28782840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
    Mulla CM; Goldfine AB; Dreyfuss JM; Houten S; Pan H; Pober DM; Wewer Albrechtsen NJ; Svane MS; Schmidt JB; Holst JJ; Craig CM; McLaughlin TL; Patti ME
    Obes Surg; 2019 Jul; 29(7):2092-2099. PubMed ID: 30976983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring.
    Ritz P; Vaurs C; Bertrand M; Anduze Y; Guillaume E; Hanaire H
    Diabetes Technol Ther; 2012 Aug; 14(8):736-40. PubMed ID: 22853724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia.
    Craig CM; Liu LF; Nguyen T; Price C; Bingham J; McLaughlin TL
    Diabetes Obes Metab; 2018 Feb; 20(2):352-361. PubMed ID: 28776922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: an update.
    Øhrstrøm CC; Worm D; Hansen DL
    Surg Obes Relat Dis; 2017 Feb; 13(2):345-351. PubMed ID: 27865808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
    Ferreira A; Schönenberger KA; Potoczna N; Vogt A; Gerber PA; Zehetner J; Giachino D; Nett P; Gawinecka J; Cossu L; Fuster DG; Dalla Man C; Facchinetti A; Melmer A; Nakas CT; Hepprich M; Donath MY; Herzig D; Bally L
    Diabetes Technol Ther; 2023 Jul; 25(7):467-475. PubMed ID: 37093196
    [No Abstract]   [Full Text] [Related]  

  • 15. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
    Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals.
    Tripyla A; Herzig D; Reverter-Branchat G; Pavan J; Schiavon M; Eugster PJ; Grouzmann E; Nakas CT; Sauvinet V; Meiller L; Zehetner J; Giachino D; Nett P; Gawinecka J; Del Favero S; Thomas A; Thevis M; Dalla Man C; Bally L
    Diabetologia; 2023 Apr; 66(4):741-753. PubMed ID: 36648553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass.
    Ferreira A; Emara AFA; Herzig D; Melmer A; Vogt AP; Nakas CT; Facchinetti A; Dalla Man C; Bally L
    BMJ Open; 2022 Sep; 12(9):e060668. PubMed ID: 36123073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
    Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
    Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.
    Poitou C; Bouaziz-Amar E; Genser L; Oppert JM; Lacorte JM; Le Beyec J
    Surg Obes Relat Dis; 2018 Jul; 14(7):929-935. PubMed ID: 29703503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass - a systematic review.
    Jalleh RJ; Umapathysivam MM; Plummer MP; Deane A; Jones KL; Horowitz M
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1075-1088. PubMed ID: 37439960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.